The U.S. shoe deodorizer market is consolidated with top three companies collectively accounting more than 50% of the market in 2013, states a new report by Transparency Market Research. These companies are Reckitt Benckiser Plc, Blistex Inc., and S.C. Johnson & Sons. However, the vast scope for product innovation and easy entry and exit in the market presents opportunities for new players in this market.
Efforts to minimize the environmental carbon footprint is one of the key focus areas of top companies in the U.S. shoe deodorizer market. The objective is to adopt a green approach and develop better products in an eco-friendly manner. A case in point is S.C. Johnson & Sons. In April 2014, the company achieved the zero landfill status across its eight manufacturing facilities in parts of the world.
Mergers and acquisitions for increasing geographical reach and for enhancing product offerings are on the roadmap of leading companies in the U.S. shoe deodorizer market. For example, Reckitt Benckiser Plc aims to augment sales by tapping into newer markets; the company currently has 19 brands in its product portfolio. Investments in R&D for product innovation and to gain a competitive advantage is also what top companies in this market are focused on.
Need to Subside Sweating Odor for Patients of Diabetes and Hyperthyroidism Fuels Market Growth
A TMR analyst says, “Increasing number of patients suffering from diabetes and hyperthyroidism in the U.S. is one of the major factors driving the U.S. shoe deodorizer market. According to statistics from the American Diabetes Association, 8.3% of the U.S. population suffers from diabetes. Diabetes affects the body in the form of poor sugar control disrupting functioning of the autonomic nervous system (ANS), which in turn causes excessive sweating of the feet and palms.
Moreover, excessive sweating due to hyperthyroidism is also driving the growth of the shoe deodorizer market. As per the American Thyroid Association, currently, almost 20 million people in the U.S. have some form of hyperthyroidism.
The rising demand for shoe deodorizers due to foot odor is also a major factor driving the growth of this market. According to the American Podiatric Medical Association (APMA), feet odor is the second prevalent foot disease in the U.S. Furthermore, an increasing prevalence of athlete’s foot is also driving the sales of shoe deodorizer in the U.S. Shoe deodorizer sprays help suppress foot odor, while deodorizer powder helps in absorbing moisture, which would otherwise provide an ideal ground for microorganisms to breed.
Chances of Developing Allergies due to Shoe Deodorizers Hamper Market Growth
Time needed for shoe deodorant spray to dry is the prime concern among consumers which is acting as a major restraint for the growth of this market. This is because wearing shoes immediately after using the deodorizer could provide the ideal environment for bacteria to breed.
“The chemical content in shoe deodorizers could develop into allergy in users,” says a TMR analyst. Shoe deodorants contain chemicals such as aluminum chlorohydrate, and high concentration of this chemical can have an adverse effect on the blood-brain barrier in the long term.
The U.S. shoe deodorizer market is expected to reach a valuation of US$319.9 mn by 2020. By product type, shoe deodorizer spray was the dominant segment in 2013 and is expected to be the leading product category in the future.
The information presented in this review is based on a Transparency Market Research report, titled “U.S. Shoe Deodorizer Market - The Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 – 2020.”
The U.S. shoe deodorizer market is segmented as follows:
U.S. shoe deodorizers market, by product type
- Shoe deodorizer powder
- Shoe deodorizer sprays
- Shoe deodorizer soles
- Shoe deodorizer balls
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453